MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Drug-induced parkinsonism(DIP)"

  • 2018 International Congress

    Parkinson’s Disease Risk in Breast Cancer

    R. Mills-Joseph (Columbus, OH, USA)

    Objective: Case report of two patients who developed symptoms of Parkinson’s disease after treatment with chemotherapy and radiation for breast cancer and to review the…
  • 2018 International Congress

    Rotenone model of Parkinson’s disease: The dosing options in mice revisited

    M. Raza, N. Zehra, S. Malhi (Karachi, Pakistan)

    Objective: In the present study we have used various dosing protocols to induce the PD-like symptoms with the administration of rotenone in mice. Background: Parkinson's…
  • 2018 International Congress

    Diagnostic Impact of Movement Disorders Subspecialty Consultations at a VA Hospital

    B. Barton (Chicago, IL, USA)

    Objective: Review the impact of subspecialty care on diagnosis patterns of patients with parkinsonism at the Jesse Brown VA (JBVA), a VA Consortium center. Background:…
  • 2017 International Congress

    Prevalence of Parkinson’s disease and Drug-induced Parkinsonism from National Health Insurance Service Claims Data (NHISCD)

    H.-I. MA, S. Jang, J.-s. Kim, S.J. Chung, J.S. Baik, Y.J. Kim (Anyang, Republic of Korea)

    Objective: To evaluate the prevalence and characteristics of of drug induced parkinsonism Background: Drug induced parkinsonism (DIP) is a clinically important disease because it can…
  • 2017 International Congress

    Drug-induced movement disorders: not a typical problem

    A. Vives-Rodriguez, A. Patel (New Haven, CT, USA)

    Objective: To characterize patients with neuroleptic drug-induced movement disorders (DIMD) referred to a single academic center Movement Disorders clinic, their causative medications and the indications…
  • 2017 International Congress

    Risk of Parkinson’s disease in zolpidem user: A systematic review and meta-analysis

    S. Hussain, A.K. Najmi, D. Anil (New Delhi, India)

    Objective: To explore the association between zolpidem use and risk of Parkinson's disorder. Background: Zolpidem is commonly prescribed for the treatment of sleep disorder. Epidemiological…
  • 2017 International Congress

    Reversible progressive supranuclear palsy-mimic induced by risperidone

    H.J. Kim, J.H. Lee (Seoul, Republic of Korea)

    Objective: To report a patient who presented with a progressive supranuclear palsy (PSP)-like syndrome while receiving risperidone that disappeared after drug withdrawal. Background: Drugs that…
  • 2017 International Congress

    Tacrolimus induced parkinsonism presenting as freezing of gait and speech

    V. Paramanandam, H. DS, P.C. N (Chennai, India)

    Objective: Tacrolimus a calcineurin inhibitor is the most widely used immunosuppressant in post transplant patients. Mild adverse effects like tremors and parasthesia and occasionally major…
  • 2017 International Congress

    All-trans-retinoic Acid pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced hemi-parkinsonian rats

    A. Morad Ganjeh (Karaj, Islamic Republic of Iran)

    Objective: This study examined the effect of pretreatment with All-trans-retinoic Acid (ATRA) on the 6-hydroxydopamine-induced Parkinsonism in Wistar rats in order to find out whether…
  • 2017 International Congress

    Corticobasal syndrome due to brain tumor

    P. Tsitsi, G. Xiromerisiou, T. Kalantzakou, T. Bourinaris, G. Deretzi (Stockholm, Sweden)

    Objective: To describe a case of a 60-year-old female that presented with cognitive decline and gait disorders for the last 7 years.   Background: The…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley